Gene Bio Systems
MET (Ab-1003) Antibody - Cat. #: CSB-PA562889
MET (Ab-1003) Antibody - Cat. #: CSB-PA562889
SKU:CSB-PA562889
Couldn't load pickup availability
Size :100ul
Clone Number:
Aliases:AUTS9 antibody; c met antibody; D249 antibody; Hepatocyte growth factor receptor antibody; HGF antibody; HGF receptor antibody; HGF/SF receptor antibody; HGFR antibody; MET antibody; Met proto oncogene antibody; Met proto oncogene tyrosine kinase antibody; MET proto oncogene; receptor tyrosine kinase antibody; Met proto-oncogene (hepatocyte growth factor receptor) antibody; Met proto-oncogene antibody; Met protooncogene antibody; MET_HUMAN antibody; Oncogene MET antibody; Par4 antibody; Proto-oncogene c-Met antibody; RCCP2 antibody; Scatter factor receptor antibody; SF receptor antibody; Tyrosine-protein kinase Met antibody
Product Type:Polyclonal Antibody
Immunogen Species:Homo sapiens (Human)
UniProt ID:P08581
Immunogen:Peptide sequence around aa. 1001~1005 (V-D-Y-R-A) derived from Human Met.
Raised in:Rabbit
Species Reactivity:Human, Mouse, Rat
Tested Applications:ELISA, WB, IHC; WB:1:500-1:1000, IHC:1:50-1:200
Background:Receptor for hepatocyte growth factor and scatter factor. Has a tyrosine-protein kinase activity. Functions in cell proliferation, scattering, morphogenesis and survival.
Weidner, K.M. et al. (1993) J. Cell Biol. 121, 145-154.
Traxler, P. et al. (2001) Med. Res. Rev. 21, 499-512.
Schaeper, U. et al. (2000) J. Cell Biol. 149, 1419-1432.
Park, M. et al. (1986) Cell 45, 895-904.
Clonality:Polyclonal
Isotype:IgG
Purification Method:Antibodies were produced by immunizing rabbits with synthetic peptide and KLH conjugates. Antibodies were purified by affinity-chromatography using epitope-specific peptide.
Conjugate:Non-conjugated
Buffer:Supplied at 1.0mg/mL in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Form:liquid
Stroage:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Target Names:MET
Research Areas:Epigenetics and Nuclear Signaling;Cancer;Signal transduction
